+
Site Tour

Webinar 2022: Management of aortic and mitral valve disease

Torsten Doenst et al. Focus on the management of aortic and mitral valve disease with future treatment in mind. Including quality of life, preserving the long-treatment path, and the role of porcine tissue valves during a recorded webinar.

Related Videos

TAVI Summit - PreTAVR CT analysis

TAVI Summit - What is coming next

TAVI Summit - Cardiac imaging and morphology

Case Parade | Mitral focus

TAVI Case-Club – Alternative access

T-TEER: patient selection and current evidence

Mechanical Heart Valve Patient Story: Sadie

Mechanical Heart Valve Patient Story: Veronika

TRENDING TOPICS

TAVI Webinar 1- Key learnings for advanced TAVI

TAVI Webinar 1- when the present unlocks the future:key learnings for advances TAVI

Treating Large annuli with 35mm Navitor Vision

Achieving optimal outcomes for treatment of large annuli with 35 mm Navitor Vision Valve

PCR Webinar on secondary mitral regurgitation

New evidence reshaping the management of secondary mitral regurgitation

CONNEXT


HUB
RELATED RESOURCES

ESOC presentation: PFO closure in patients > 60 Years

PCR LV 2021: Navitor™ Live-in-a-box

PCR LV 2021: Navitor™ Looking ahead

Epic Mitral – 10-Year Clinical Outcomes

CONNEXT


LIVE
RELATED EVENTS

AV VALVES 2023: Staged, Concomitant

Now you've got Navitor.
Future ready.

EACVI Summit 2023: Congress symposium

AV VALVES 2023: HoloLens Technology

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline